Onsight Platforms

A growing menu of Onsight-enabled tests

The Onsight ecosystem is designed as a flexible platform. One meter and app can support multiple analytes through disease-specific strips and algorithms.

PKU Now

A home and point-of-care platform in development to quantify blood phenylalanine for people living with phenylketonuria (PKU). PKU Now provides the test, smart workflows, data visualization, and a connected web dashboard for clinicians.

  • Analyte: Phenylalanine (Phe)
  • Condition: PKU
  • Intended use: Home and clinic monitoring of Phe levels
  • Sample type: Capillary blood (finger- or heel-stick)

PreQuine – G6PD deficiency

PreQuine is a point-of-care platform for simultaneous, quantitative measurement of G6PD enzyme activity and hemoglobin in a single small blood sample, designed to support safer use of oxidant drugs in malaria and related settings.

  • Analytes: G6PD enzyme, hemoglobin
  • Condition: G6PD deficiency, anemia risk
  • Intended use: Point-of-care screening and monitoring

ADA2 Now – ADA2 deficiency (DADA2)

ADA2 Now is being developed as a rapid, point-of-care blood test to quantify ADA2 enzyme levels to support diagnosis and monitoring of DADA2.

  • Analyte: ADA2 enzyme activity
  • Condition: Deficiency of adenosine deaminase 2 (DADA2)
  • Intended use: Near-patient diagnosis and follow-up

CPK Now

CPK Now is a rapid blood test intended to measure creatine phosphokinase (CPK) at the point of care, with app-based result storage to support management of conditions such as long-chain fatty acid oxidation disorders and recurrent rhabdomyolysis.

HCY Now

HCY Now is a planned assay for homocysteine, targeting cardiovascular and metabolic risk assessment where fast, decentralized measurement may add value.

Bili Now

Bili Now is a point-of-care bilirubin test in development for neonatal intensive care and nursery settings, aimed at early detection of elevated bilirubin to help prevent bilirubin-induced neurologic damage.

Hb Now

Hb Now is conceived as an affordable, portable test for hemoglobin levels that connects to a mobile app for secure result tracking and remote review.

Pipeline and Regulatory Note

Assays are at different stages of research, validation, and regulatory review. Products described here are investigational and not yet cleared or approved for routine clinical use; availability will vary by region and over time.